Radiolabeled anti–prostate-specific membrane antigen (PSMA) monoclonal antibody J591 for metastatic castration-resistant prostate cancer (CRPC).
Impact of interstitial brachytherapy (IB) or radical prostatectomy (RP) on quality of life (QL) of patients (pts) treated for localized prostate cancer (LPC): Medium-term outcomes from a prospective ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果